Cuba tested prostate cancer vaccine

Cuban scientists said on Sept. 24 that they had completed a second clinical trial of a vaccine that could fight prostate cancer.

>>>New treatment for prostate cancer

Urology doctor Ranfis Rodriguez said the health status of 56 patients improved markedly after being vaccinated with Heber Provac at two hospitals.

Mr. Rodriguez, head of the research team at the Center for Genetic Engineering and Biotechnology (CIGB) in Camaguey City, 530km east of Havana, said Heber Provac's vaccine has reduced the antigen-specific antigen. Paralysis (PSA) with little or no production of male sex hormones, which is a hormone that stimulates prostate cancer cells.

Vaccine Heber Provac is used in the late stages of prostate cancer and before the patient is given radiation or chemotherapy.

Mr. Jesus Junco, another expert at CIGB, said that Heber Provac vaccine, prepared to protect against stage 3 and 4 cancers, will be equally effective or higher than the standard treatments. future standards.

Scientists will study the interaction of Heber Provac vaccine with other drugs and conduct comparisons with the standard medicines and treatments used to fight prostate cancer.

Each year more than 2,500 men suffer from prostate cancer in Cuba, mostly over 60 years old and 60% of deaths.